Rollins Other Non-Current Liabilities increased by 11.5% to $88.27M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.1%, from $70.55M to $88.27M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 17.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $36.37M | $32.58M | $31.55M | $32.22M | $32.47M | $35.26M | $38.35M | $40.58M | $45.66M | $43.91M | $48.06M | $51.93M | $57.60M | $57.51M | $61.95M | $70.55M | $57.71M | $77.55M | $79.16M | $88.27M |
| QoQ Change | — | -10.4% | -3.2% | +2.1% | +0.8% | +8.6% | +8.8% | +5.8% | +12.5% | -3.8% | +9.4% | +8.0% | +10.9% | -0.2% | +7.7% | +13.9% | -18.2% | +34.4% | +2.1% | +11.5% |
| YoY Change | — | — | — | — | -10.7% | +8.2% | +21.6% | +26.0% | +40.6% | +24.5% | +25.3% | +28.0% | +26.2% | +31.0% | +28.9% | +35.9% | +0.2% | +34.8% | +27.8% | +25.1% |